Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2016

01-04-2016 | Original Paper

Opt-Out HIV Testing of Inmates in North Carolina Prisons: Factors Associated with not Wanting a Test and not Knowing They Were Tested

Authors: Catherine A. Grodensky, David L. Rosen, Sayaka Hino, Carol E. Golin, David A. Wohl

Published in: AIDS and Behavior | Issue 4/2016

Login to get access

Abstract

Opt-out HIV testing is recommended for correctional settings but may occur without inmates’ knowledge or against their wishes. Through surveying inmates receiving opt-out testing in a large prison system, we estimated the proportion unaware of being tested or not wanting a test, and associations [prevalence ratios (PRs)] with inmate characteristics. Of 871 tested, 11.8 % were unknowingly tested and 10.8 % had unwanted tests. Not attending an educational HIV course [PR = 2.34, 95 % confidence interval (CI) 1.47–3.74], lower HIV knowledge (PR = 0.95, 95 % CI 0.91–0.98), and thinking testing is not mandatory (PR = 9.84, 95 % CI 4.93–19.67) were associated with unawareness of testing. No prior incarcerations (PR = 1.59, 95 % CI 1.03–2.46) and not using crack/cocaine recently (PR = 2.37, 95 % CI 1.21–4.64) were associated with unwanted testing. Residence at specific facilities was associated with both outcomes. Increased assessment of inmate understanding and enhanced implementation are needed to ensure inmates receive full benefits of opt-out testing: being informed and tested according to their wishes.
Literature
1.
Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One. 2009;4(11):e7558.CrossRefPubMedPubMedCentral
2.
Westergaard RP, Spaulding AC, Flanigan T. HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis. 2013;26(1):10–6.CrossRefPubMedPubMedCentral
3.
Seal DW, Eldridge GD, Zack B, Sosman J. HIV testing and treatment with correctional populations: people, not prisoners. J Health Care Poor Unders. 2010;21(3):977–85.CrossRef
4.
Beckwith CG, Zaller ND, Fu JJ, Montague BT, Rich JD. Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J Acquir Immune Defic Syndr. 2010;55(Suppl 1):S49–55.CrossRefPubMedPubMedCentral
5.
VanHandel M, Beltrami JF, MacGowan RJ, Borkowf CB, Margolis AD. Newly identified HIV infections in correctional facilities, United States, 2007. Am J Public Health. 2012;102(Suppl 2):S201–4.CrossRefPubMedPubMedCentral
6.
Maruschak L, Beavers R. HIV in Prisons, 2007–2008: Bureau of Justice Statistics2009. Report No. NCJ 228307.
7.
8.
WHO. Health in prisons: A WHO guide to the essentials in prison health: WHO Regional Office for Europe; 2007.
9.
Rennie S, Behets F. Desperately seeking targets: the ethics of routine HIV testing in low-income countries. Bull World Health Organ. 2006;84(1):52–7.CrossRefPubMedPubMedCentral
10.
Malek M, Bazazi AR, Cox G, Rival G, Baillargeon J, Miranda A, et al. Implementing opt-out programs at Los Angeles county jail: a gateway to novel research and interventions. J Correct Health Care. 2011;17(1):69–76.CrossRefPubMedPubMedCentral
11.
CDC. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55(RR14):1–17.
12.
Maruschak L, Berzofsky M, Unangst J. Medical Problems of State and Federal Prisoners and Jail Inmates, 2011–12: Bureau of Justice Statistics 2015. Report No.: NCJ 248491.
13.
Beckwith CG, Nunn A, Baucom S, Getachew A, Akinwumi A, Herdman B, et al. Rapid HIV testing in large urban jails. Am J Public Health. 2012;102(S2):S184–6.CrossRefPubMedPubMedCentral
14.
Grinstead O, Seal DW, Wolitski R, Flanigan T, Fitzgerald C, Nealey-Moore J, et al. HIV and STD testing in prisons: perspectives of in-prison service providers. AIDS Educ Prev. 2003;15(6):547–60.CrossRefPubMed
15.
Rosen DL, Golin CE, Grodensky CA, May J, Bowling JM, DeVellis RF, et al. Opt-out HIV testing in prison: informed and voluntary? AIDS Care. 2015;27(5):545–54.CrossRefPubMed
16.
Ostermann J, Kumar V, Pence BW, Whetten K. Trends in HIV testing and differences between planned and actual testing in the United States, 2000–2005. Arch Int Med. 2007;167(19):2128–35.CrossRef
17.
18.
Asaoka K, Shoji H, Nishizaka S, Ayabe M, Abe T, Ohori N, et al. Non-herpetic acute limbic encephalitis: cerebrospinal fluid cytokines and magnetic resonance imaging findings. Int Med. 2004;43(1):42–8.CrossRef
19.
Ochtera RD. Conceptualizing HIV-associated stigma and exploring the correlates of HIV testing behaviors for incarcerated men in North Carolina. Chapel Hill: University of North Carolina at Chapel Hill; 2012.
20.
Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.CrossRefPubMed
21.
Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57:13–24.CrossRefPubMed
22.
23.
CDC. HIV screening of male inmates during prison intake medical evaluation—Washington, 2006–2010. MMWR. 2011;60(24):811–3.
24.
Haukoos JS, Hopkins E, Bender B, Al-Tayyib A, Long J, Harvey J, et al. Use of kiosks and patient understanding of opt-out and opt-in consent for routine rapid human immunodeficiency virus screening in the emergency department. Acad Emerg Med. 2012;19(3):287–93.CrossRefPubMed
25.
Ujiji OA, Rubenson B, Ilako F, Marrone G, Wamalwa D, Wangalwa G, et al. Is ‘Opt-Out HIV Testing’ a real option among pregnant women in rural districts in Kenya? BMC Public Health. 2011;11:151.CrossRefPubMedPubMedCentral
26.
Mugore L, Engelsmann B, Ndoro T, Dabis F, Perez F. An assessment of the understanding of the offer of routine HIV testing among pregnant women in rural Zimbabwe. AIDS Care. 2008;20(6):660–6.CrossRefPubMed
27.
Emerson GG, Smith JR, Wilson DJ, Rosenbaum JT, Flaxel CJ. Primary treatment of acute retinal necrosis with oral antiviral therapy. Ophthalmology. 2006;113(12):2259–61.CrossRefPubMed
28.
Walker J, Sanchez R, Davids J, Stevens M, Whitehorn L, Greenspan J, et al. Is routine testing mandatory or voluntary? Clin Infect Dis. 2005;40(2):319.CrossRefPubMed
29.
Courtenay WH. Behavioral factors associated with disease, injury, and death among men: evidence and implications for prevention. J Mens Stud. 2000;9(1):81–142.CrossRef
30.
Wenzel SL, Rhoades H, Tucker JS, Golinelli D, Kennedy DP, Zhou A, et al. HIV risk behavior and access to services: what predicts HIV testing among heterosexually active homeless men? AIDS Educ Prev. 2012;24(3):270–9.CrossRefPubMedPubMedCentral
31.
Al-Zarzour N, Monem F. Are human herpes viruses associated with autoimmune thyroid disease? J Infect Dev Ctries. 2011;5(12):890–2.CrossRefPubMed
32.
Derlega VJ, Winstead BA, Brockington JE. AIDS stigma among inmates and staff in a USA state prison. Int J STD AIDS. 2008;19(4):259–63.CrossRefPubMed
33.
Snell WE, Finney PD, Godwin LJ. Stereotypes about AIDS. Contemp Soc Psychol. 1991;15:18–38.
Metadata
Title
Opt-Out HIV Testing of Inmates in North Carolina Prisons: Factors Associated with not Wanting a Test and not Knowing They Were Tested
Authors
Catherine A. Grodensky
David L. Rosen
Sayaka Hino
Carol E. Golin
David A. Wohl
Publication date
01-04-2016
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2016
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-015-1203-y

Other articles of this Issue 4/2016

AIDS and Behavior 4/2016 Go to the issue

Erratum

Erratum to: Promoting Female Condom Use Among Female University Students in KwaZulu-Natal, South Africa: Results of a Randomized Behavioral Trial

Original Paper

Do High-Risk Young Adults Use the HIV Self-Test Appropriately? Observations from a Think-Aloud Study

Original Paper

Exploring the Impact of Childhood Abuse on HIV Social and Attitudinal Factors Among Adults With and Without this History in Sub-Saharan Africa: Findings from NIMH Project Accept (HPTN 043)

Substantive Review

Masculinity and HIV: Dimensions of Masculine Norms that Contribute to Men’s HIV-Related Sexual Behaviors

Brief Report

Gay-Related Rejection Sensitivity as a Risk Factor for Condomless Sex

Original Paper

Which Psychological Factors are Related to HIV Testing? A Quantitative Systematic Review of Global Studies
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits